New Mesothelioma Drug Turns Cancer’s Own Defenses Against It
5 Articles
5 Articles
Science Daily
MSNBCTV NEWSNew mesothelioma drug turns cancer’s own defenses against it
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could…
A new study by researchers at the University of Vermont (UVM) and international collaborators, published in Nature Communications, presents a different therapeutic strategy for mesothelioma. Like many cancer cells, mesothelioma cells produce large amounts of reactive oxygen species (ROS), unstable molecules that can cause cellular damage. To survive this […] The post Good news for a type of cancer with a poor prognosis appeared first on iEidisei…
Researchers at the University of Vermont have developed a new experimental drug for the treatment of mesothelioma, an aggressive cancer associated with exposure to asbestos. The innovative approach uses the antioxidant defenses of the cells...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
